ETX.L Regulatory News (ETX)

e-Therapeutics plc

Notice of Preliminary Results

e-Therapeutics plc (AIM: ETX), the drug discovery and development company, will be announcing its final results for the 12 month period ending 31st January 2011 on Monday 25th July 2011.

Professor Malcolm Young, CEO, Daniel Elger, CFO, and Stephen Self, Development Director, will be hosting a presentation for analysts at 9.30am on the morning of the results at the offices of College Hill, The Registry, Royal Mint Court, EC3N 4QN.

-Ends-

For more information, please contact:

e-Therapeutics plc

Malcolm Young

Tel: +44 (0) 191 233 1317

Daniel Elger

Tel: +44 (0) 7909 915 068

www.etherapeutics.co.uk 

Panmure Gordon (UK) Limited

Andrew Burnett / Aubrey Powell

Tel: +44 (0) 20 7459 3600

www.panmure.com

College Hill

Melanie Toyne Sewell/Jayne Crook

Tel: +44 (0) 20 7457 2020

Email: e-therapeutics@collegehill.com